ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MBOT vs LUCD // RSI-14 & 200D SMA MOMENTUM

Microbot Medical Inc. (NASDAQ) VS. Lucid Diagnostics Inc. (NASDAQ) • 15-METRIC TALLY: MBOT 2 — LUCD 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: MBOT
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MBOT VS. LUCD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MBOT LUCD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -15.80% -35.00% +19.20 MBOT /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.42% — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 48.5 36.1 +12.39 MBOT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $75.2M $87.9M -$12.6M LUCD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MBOT REV LUCD REV MBOT GROSS % LUCD GROSS % MBOT FCF LUCD FCF
FY 2025 $0 $0 — — -$13.1M -$46.7M
FY 2024 $0 $4.3M — -50.0% -$8.9M -$44.4M
FY 2023 $0 $2.4M — — -$8.5M -$32.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MBOT // BETA —
LUCD // BETA —